Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription

Articles published in Eur J Radiol

Retrieve available abstracts of 77 articles:
HTML format

Single Articles

    January 2024
  1. GIGANTI F, Asbach P
    The backbone of prostate MRI: Technical acquisition and image quality.
    Eur J Radiol. 2024;172:111320.

    December 2023
  2. REN X, Nur Salihin Yusoff M, Hartini Mohd Taib N, Zhang L, et al
    (68)Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head comparative meta-analysis.
    Eur J Radiol. 2023;170:111274.
    PubMed     Abstract available

  3. HARTH C, De Vulder N, Hermie L, Vanlangenhove P, et al
    Stereotactic transgluteal prostatic biopsy using Cone-Beam CT navigation and prebiopsy MRI image fusion in a patient without rectal access.
    Eur J Radiol. 2023;170:111265.

  4. KHAN A, Moore CM, Minhaj Siddiqui M
    Prostate MRI and image quality: The urologist's perspective.
    Eur J Radiol. 2023;170:111255.
    PubMed     Abstract available

  5. WENDEROTT K, Krups J, Luetkens JA, Gambashidze N, et al
    Prospective effects of an artificial intelligence-based computer-aided detection system for prostate imaging on routine workflow and radiologists' outcomes.
    Eur J Radiol. 2023;170:111252.
    PubMed     Abstract available

    November 2023
  6. PAUSCH AM, Ghafoor S, Kluckert J, Rupp NJ, et al
    Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters.
    Eur J Radiol. 2023;170:111227.
    PubMed     Abstract available

  7. AGGARWAL P, Singh H, Das CK, Mavuduru RS, et al
    Potential role of (68)Ga-PSMA PET/CT in metastatic renal cell cancer: A prospective study.
    Eur J Radiol. 2023;170:111218.
    PubMed     Abstract available

  8. REHMAN I, Pang E, Harris AC, Chang SD, et al
    Bi-parametric prostate MRI with a recall system for contrast enhanced imaging: Improving accessibility while maintaining quality.
    Eur J Radiol. 2023;169:111186.
    PubMed     Abstract available

  9. FLEMING H, Dias AB, Talbot N, Li X, et al
    Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting.
    Eur J Radiol. 2023;168:111091.
    PubMed     Abstract available

    October 2023
  10. AL-MONAJJED R, Radtke JP, Thomas M, Boschheidgen M, et al
    Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer.
    Eur J Radiol. 2023;169:111151.
    PubMed     Abstract available

  11. ZHANG KS, Mayer P, Glemser PA, Tavakoli AA, et al
    Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
    Eur J Radiol. 2023;167:111026.
    PubMed     Abstract available

  12. SABBAH M, Gutierrez P, Puech P
    MA-QC: Free online software for prostate MR quality control and PI-QUAL assessment.
    Eur J Radiol. 2023;167:111027.
    PubMed     Abstract available

    September 2023
  13. SINGH S, Giganti F, Dickinson L, Rogers H, et al
    Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.
    Eur J Radiol. 2023;168:111109.
    PubMed     Abstract available

  14. YILMAZ EC, Harmon SA, Belue MJ, Merriman KM, et al
    Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
    Eur J Radiol. 2023;168:111095.
    PubMed     Abstract available

  15. ROBERTSON SH, Owenby E, Beasley C, Wall L, et al
    Optimization of non-endorectal prostate MR image quality using PI-QUAL: A multidisciplinary team approach.
    Eur J Radiol. 2023;166:110998.
    PubMed     Abstract available

  16. PONSIGLIONE A, Campo I, Sachs C, Sofia C, et al
    Extraprostatic incidental findings on prostate mpMRI: A pictorial review from the ESUR junior network.
    Eur J Radiol. 2023;166:110984.
    PubMed     Abstract available

    August 2023
  17. FENNESSY FM, Maier SE
    Quantitative diffusion MRI in prostate cancer: Image quality, what we can measure and how it improves clinical assessment.
    Eur J Radiol. 2023;167:111066.
    PubMed     Abstract available

  18. GIROMETTI R, Giannarini G, De Martino M, Caregnato E, et al
    Multivariable stratification of PI-RADS version 2.1 categories for the risk of false-positive target biopsy: Impact on prostate biopsy decisions.
    Eur J Radiol. 2023;165:110897.
    PubMed     Abstract available

  19. THIJSSEN LCP, de Rooij M, Barentsz JO, Huisman HJ, et al
    Radiomics based automated quality assessment for T2W prostate MR images.
    Eur J Radiol. 2023;165:110928.
    PubMed     Abstract available

  20. DEIVASIGAMANI S, Kotamarti S, Adams ES, Seguier D, et al
    Reconciling discordance between PI-RADS 4 lesions and targeted biopsy: Early experience of a multidisciplinary quality improvement protocol with PI-RADS 4 subcategorization.
    Eur J Radiol. 2023;165:110929.
    PubMed     Abstract available

    July 2023
  21. LEE KL, Kessler DA, Dezonie S, Chishaya W, et al
    Assessment of deep learning-based reconstruction on T2-weighted and diffusion-weighted prostate MRI image quality.
    Eur J Radiol. 2023;166:111017.
    PubMed     Abstract available

  22. BRILLAT-SAVARIN N, Wu C, Aupin L, Thoumin C, et al
    3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score.
    Eur J Radiol. 2023;166:110974.
    PubMed     Abstract available

  23. PONSIGLIONE A, Stanzione A, Califano G, De Giorgi M, et al
    MR image quality in local staging of prostate cancer: Role of PI-QUAL in the detection of extraprostatic extension.
    Eur J Radiol. 2023;166:110973.
    PubMed     Abstract available

  24. SEYREK N, Hollemans E, Schoots IG, van Leenders GJLH, et al
    Association of quantifiable prostate MRI parameters with any and large cribriform pattern in prostate cancer patients undergoing radical prostatectomy.
    Eur J Radiol. 2023;166:110966.
    PubMed     Abstract available

    June 2023
  25. BECKER AS, Giganti F, Purysko AS, Fainberg J, et al
    Taking PI-QUAL beyond the prostate: Towards a standardized radiological image quality score (RI-QUAL).
    Eur J Radiol. 2023;165:110955.
    PubMed     Abstract available

  26. URSPRUNG S, Herrmann J, Joos N, Weiland E, et al
    Accelerated diffusion-weighted imaging of the prostate using deep learning image reconstruction: A retrospective comparison with standard diffusion-weighted imaging.
    Eur J Radiol. 2023;165:110953.
    PubMed     Abstract available

  27. MOLLER JM, Boesen L, Hansen AE, Kettles K, et al
    Quantification of cross-vendor variation in ADC measurements in vendor-specific prostate MRI-protocols.
    Eur J Radiol. 2023;165:110942.
    PubMed     Abstract available

  28. PURYSKO AS, Tempany C, Macura KJ, Turkbey B, et al
    American College of Radiology initiatives on prostate magnetic resonance imaging quality.
    Eur J Radiol. 2023;165:110937.
    PubMed     Abstract available

  29. FUTTERER JJ, Tempany C
    Prostate MRI and image quality: The radiologist's perspective.
    Eur J Radiol. 2023;165:110930.
    PubMed     Abstract available

  30. ALIS D, Kartal MS, Seker ME, Guroz B, et al
    Deep learning for assessing image quality in bi-parametric prostate MRI: A feasibility study.
    Eur J Radiol. 2023;165:110924.
    PubMed     Abstract available

  31. BASAR Y, Alis D, Seker ME, Kartal MS, et al
    Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study.
    Eur J Radiol. 2023;165:110923.
    PubMed     Abstract available

  32. COELHO FMA, Amaral LTW, Mitsutake LKN, Mussi TC, et al
    Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
    Eur J Radiol. 2023;165:110921.
    PubMed     Abstract available

  33. ZHANG KS, Neelsen CJO, Wennmann M, Glemser PA, et al
    Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
    Eur J Radiol. 2023;165:110898.
    PubMed     Abstract available

    May 2023
  34. KIM H, Kang SW, Kim JH, Nagar H, et al
    The role of AI in prostate MRI quality and interpretation: Opportunities and challenges.
    Eur J Radiol. 2023;165:110887.
    PubMed     Abstract available

  35. DE OLIVEIRA CORREIA ET, Qiao PL, Griswold MA, Chen Y, et al
    Magnetic resonance fingerprinting based comprehensive quantification of T1 and T2 values of the background prostatic peripheral zone: Correlation with clinical and demographic features.
    Eur J Radiol. 2023;164:110883.
    PubMed     Abstract available

  36. WANG R, Pinto D, Liu T, Hamade M, et al
    Effect of a dedicated PI-QUAL curriculum on the assessment of prostate MRI quality.
    Eur J Radiol. 2023;164:110865.
    PubMed     Abstract available

  37. GIROMETTI R, Giannarini G, Peruzzi V, Amparore D, et al
    MRI-informed prostate biopsy: What the radiologist should know on quality in biopsy planning and biopsy acquisition.
    Eur J Radiol. 2023;164:110852.
    PubMed     Abstract available

  38. ROGERS HJ, Singh S, Barnes A, Obuchowski NA, et al
    Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.
    Eur J Radiol. 2023;162:110782.
    PubMed     Abstract available

    April 2023
  39. BREMBILLA G, Lavalle S, Parry T, Cosenza M, et al
    Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy.
    Eur J Radiol. 2023;164:110849.
    PubMed     Abstract available

    March 2023
  40. WOERNLE A, Dickinson L, Lelie S, Pendse D, et al
    A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.
    Eur J Radiol. 2023;162:110796.
    PubMed     Abstract available

  41. UEDA T, Ohno Y, Shinohara M, Yamamoto K, et al
    Reverse encoding distortion correction for diffusion-weighted MRI: Efficacy for improving image quality and ADC evaluation for differentiating malignant from benign areas in suspected prostatic cancer patients.
    Eur J Radiol. 2023;162:110764.
    PubMed     Abstract available

  42. GHAFOOR S, Steinebrunner F, Stocker D, Hotker AM, et al
    Index lesion contouring on prostate MRI for targeted MRI/US fusion biopsy - Evaluation of mismatch between radiologists and urologists.
    Eur J Radiol. 2023;162:110763.
    PubMed     Abstract available

    February 2023
  43. PRABHAKAR S, Schieda N
    Patient preparation for prostate MRI: A scoping review.
    Eur J Radiol. 2023;162:110758.
    PubMed     Abstract available

  44. LIN Y, Yilmaz EC, Belue MJ, Turkbey B, et al
    Prostate MRI and image Quality: It is time to take stock.
    Eur J Radiol. 2023;161:110757.
    PubMed     Abstract available

  45. FOROOKHI A, Laschena L, Pecoraro M, Borrelli A, et al
    Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice an
    Eur J Radiol. 2023;161:110749.
    PubMed     Abstract available

  46. HOTKER AM, Njoh S, Hofer LJ, Held U, et al
    Multi-reader evaluation of different image quality scoring systems in prostate MRI.
    Eur J Radiol. 2023;161:110733.
    PubMed     Abstract available

    January 2023
  47. TOKUDA B, Yamada K, Takahata A, Fujihara A, et al
    Time-course changes in multiparametric magnetic resonance imaging following focal cryotherapy for localized prostate cancer: Initial experience.
    Eur J Radiol. 2023;160:110714.
    PubMed     Abstract available

  48. VILANOVA JC, Perez de Tudela A, Thio-Henestrosa S, Barcelo J, et al
    Usefulness of balanced SSFP sequence in robot-assisted MRI-guided prostate biopsy: Beyond scouting.
    Eur J Radiol. 2023;160:110707.
    PubMed     Abstract available

    November 2022
  49. KUROKAWA R, Kato S, Koyama H, Ishida M, et al
    Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer.
    Eur J Radiol. 2022;157:110595.
    PubMed     Abstract available

    September 2022
  50. ZIAYEE F, Schimmoller L, Blondin D, Boschheidgen M, et al
    Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection.
    Eur J Radiol. 2022;156:110520.
    PubMed     Abstract available

    August 2022
  51. ALFANO R, Bauman GS, Gomez JA, Gaed M, et al
    Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology.
    Eur J Radiol. 2022;156:110494.
    PubMed     Abstract available

    July 2022
  52. POTSCH N, Rainer E, Clauser P, Vatteroni G, et al
    Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population.
    Eur J Radiol. 2022;154:110431.
    PubMed     Abstract available

  53. DORFINGER J, Ponholzer A, Stolzlechner M, Lenart S, et al
    MRI/ultrasound fusion biopsy of the prostate compared to systematic prostate biopsy - Effectiveness and accuracy of a combined approach in daily clinical practice.
    Eur J Radiol. 2022;154:110432.
    PubMed     Abstract available

    March 2022
  54. CAGLIC I, Sushentsev N, Colarieti A, Warren AY, et al
    Value of the capsular enhancement sign on dynamic contrast-enhanced prostate multiparametric MRI for the detection of extracapsular extension.
    Eur J Radiol. 2022;150:110275.
    PubMed     Abstract available

  55. YANG L, Li M, Zhang MN, Yao J, et al
    Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: A multiparametric MRI study according to PI-RADS version 2.1.
    Eur J Radiol. 2022;150:110268.
    PubMed     Abstract available

  56. GIROMETTI R, Blandino A, Zichichi C, Cicero G, et al
    Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study.
    Eur J Radiol. 2022;150:110267.
    PubMed     Abstract available

    February 2022
  57. ASFUROGLU U, Asfuroglu BB, Ozer H, Gonul II, et al
    Which one is better for predicting extraprostatic extension on multiparametric MRI: ESUR score, Likert scale, tumor contact length, or EPE grade?
    Eur J Radiol. 2022;149:110228.
    PubMed     Abstract available

    January 2022
  58. ARNOLDNER MA, Polanec SH, Lazar M, Kadhjavi S, et al
    Rectal preparation significantly improves prostate imaging quality: Assessment of the PI-QUAL score with visual grading characteristics.
    Eur J Radiol. 2022;147:110145.
    PubMed     Abstract available

    December 2021
  59. VALENTIN B, Arsov C, Ullrich T, Demetrescu D, et al
    Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer.
    Eur J Radiol. 2021;147:110110.
    PubMed     Abstract available

    November 2021
  60. HAGEN F, Norz V, Thaiss WM, Mair A, et al
    Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Eur J Radiol. 2021;146:110059.
    PubMed     Abstract available

  61. SKAWRAN SM, Sanchez V, Ghafoor S, Hotker AM, et al
    Primary staging in patients with intermediate- and high-risk prostate cancer: Multiparametric MRI and (68)Ga-PSMA-PET/MRI - What is the value of quantitative data from multiparametric MRI alone or in conjunction with clinical information?
    Eur J Radiol. 2021;146:110044.
    PubMed     Abstract available

    October 2021
  62. CHOI MH, Lee SW, Kim HG, Kim JY, et al
    3D MR fingerprinting (MRF) for simultaneous T1 and T2 quantification of the bone metastasis: Initial validation in prostate cancer patients.
    Eur J Radiol. 2021;144:109990.
    PubMed     Abstract available

    September 2021
  63. SCHAUDINN A, Michaelis J, Franz T, Ho-Thi P, et al
    High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients.
    Eur J Radiol. 2021;144:109957.
    PubMed     Abstract available

  64. BOSCHHEIDGEN M, Ullrich T, Blondin D, Ziayee F, et al
    Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate.
    Eur J Radiol. 2021;144:109949.
    PubMed     Abstract available

  65. FERDINANDUS J, Fendler WP, Morigi JJ, Fanti S, et al
    Theranostics in oncology: What radiologists want to know.
    Eur J Radiol. 2021;142:109875.
    PubMed     Abstract available

    August 2021
  66. LI Z, Dan G, Tammana V, Johnson S, et al
    Predicting the aggressiveness of peripheral zone prostate cancer using a fractional order calculus diffusion model.
    Eur J Radiol. 2021;143:109913.
    PubMed     Abstract available

  67. LI W, Dong A, Hong G, Shang W, et al
    Diagnostic performance of ESUR scoring system for extraprostatic prostate cancer extension: A meta-analysis.
    Eur J Radiol. 2021;143:109896.
    PubMed     Abstract available

  68. MORADI F, Farolfi A, Fanti S, Iagaru A, et al
    Prostate cancer: Molecular imaging and MRI.
    Eur J Radiol. 2021;143:109893.
    PubMed     Abstract available

  69. YOUN SY, Choi MH, Kim DH, Lee YJ, et al
    Detection and PI-RADS classification of focal lesions in prostate MRI: Performance comparison between a deep learning-based algorithm (DLA) and radiologists with various levels of experience.
    Eur J Radiol. 2021;142:109894.
    PubMed     Abstract available

    June 2021
  70. GMEINER J, Garstka N, Helbich TH, Shariat SF, et al
    Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Eur J Radiol. 2021;142:109829.
    PubMed     Abstract available

    May 2021
  71. ARSLAN A, Alis D, Tuna MB, Saglican Y, et al
    The visibility of prostate cancer concerning underlying histopathological variances: A single-center multiparametric magnetic resonance imaging study.
    Eur J Radiol. 2021;141:109791.
    PubMed     Abstract available

  72. CAGLIC I, Sushentsev N, Shah N, Warren AY, et al
    Comparison of biparametric versus multiparametric prostate MRI for the detection of extracapsular extension and seminal vesicle invasion in biopsy naive patients.
    Eur J Radiol. 2021;141:109804.
    PubMed     Abstract available

  73. VURAL M, Coskun B, Kilic M, Durmaz S, et al
    In-bore MRI-guided prostate biopsy in a patient group with PI-RADS 4 and 5 targets: A single center experience.
    Eur J Radiol. 2021;141:109785.
    PubMed     Abstract available

    April 2021
  74. PONSIGLIONE A, Stanzione A, Imbriaco M
    Letter to the Editor regarding "Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI".
    Eur J Radiol. 2021;139:109721.

    February 2021
  75. GASSENMAIER S, Afat S, Nickel D, Mostapha M, et al
    Deep learning-accelerated T2-weighted imaging of the prostate: Reduction of acquisition time and improvement of image quality.
    Eur J Radiol. 2021;137:109600.
    PubMed     Abstract available

  76. REGIS L, Salazar A, Planas J, Celma A, et al
    The position of urethrovesical anastomosis after robotic radical prostatectomy assessed by MRI predicts early functional recovery: A cohort analyses from a randomized clinical trial.
    Eur J Radiol. 2021;137:109589.
    PubMed     Abstract available

    January 2021
  77. TAKAHASHI H, Froemming AT, Bruining DH, Karnes RJ, et al
    Prostate MRI characteristics in patients with inflammatory bowel disease.
    Eur J Radiol. 2021;135:109503.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.